Improving Disease Management through Innovative Microbiology Solutions

DeepChek®
Genotyping through NGS & Sanger Sequencing
  • HIV
  • SARS CoV-2
  • HCV
  • TB
  • 16S RNA
More information
UltraGene®
RT-PCR Solutions for Molecular Detection
  • SARS CoV-2
  • Dengue
  • Zika
More information
Digital Solutions
  • Analysis software
  • Data hosting
  • Lab automation
  • Nadis® (Computerized medical record)
More information
Microbiological Specimen Transport and Collection Kits
  • Saliva Preservation Kits
  • Wastewater Collection Kit
  • Surface Collection Kit
  • Inactivation and Preservation Solution
More information
Instruments & Consumables
  • DNA/RNA extraction
  • Real-time PCR systems
  • Liquid handling robots
  • Next-Generation Sequencing (NGS)
  • SANGER sequencing
More information

ABL DIAGNOSTICS EXPANDS ITS HIV GENOTYPING ASSAYS OFFERING

November 30, 2023

Woippy (France) – ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories is pleased to announce the expansion of its HIV genotyping menu of applications with the release of a new revolutionary assay, DeepChek® Assay HIV-1 Full PR/RT/INT Drug Resistance. The company keeps innovating

Read More »

ABL Diagnostics expands its commercial network and collaborations to offer unique Sanger & NGS based microbiology genotyping assays and software worldwide.

November 24, 2023

Woippy (France) – ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories is pleased to announce today the expansion of its network of exclusive distributors, able to offer the DeepChek® technology to laboratories willing to implement microbiology applications like HIV, SARS-CoV-2, Tuberculosis, Cytomegalovirus, Viral

Read More »

Subscribe to our newsletter

Scroll to Top